Seniors’ misconceptions about advanced cancer may reduce use of hospice services: study
Mar 02, 2022
Older adults with advanced cancer often misjudge the time they have left to live. This may increase their chances for unnecessary hospitalization and likelihood to neglect hospice care, investigators say.
Unnecessary RT given near end of life in metastatic cancer
Jan 18, 2022
Guideline-nonconcordant radiotherapy given to substantial proportion of Medicare beneficiaries with metastatic cancer near the end of life
Cancer patients well-protected against COVID-19 with vaccines: study
Dec 14, 2021
The mRNA-based COVID-19 vaccines are effective at preventing infection in most cancer patients, according to a nationwide study of veterans diagnosed with cancer in the past decade.
Colorectal cancer risk up for patients with psoriasis
Nov 30, 2021
In subgroup analysis according to sex, increased risk for CRC seen for female, but not male psoriasis patients
Seniors have fewer chemotherapy side effects with supportive care program, clinical trial finds
Oct 01, 2021
Patients in the intervention group experienced a 10% reduction in moderate side effects — without significant chemotherapy modifications or dose reductions, investigators say.
Medicare and Medicaid recipients, minorities receive more low-value, aggressive cancer care at end of...
Sep 23, 2021
Investigators found that people of Black and Asian or Pacific Islander race, Hispanic ethnicity, with public insurance status, and who were admitted to an urban teaching hospital were more likely to receive...
Mortality risk increased for MS patients soon after CRC diagnosis
Sep 16, 2021
Associations between MS and all-cause, cancer-specific death partially attenuated after adjustment for disability status
Which cancer patients need a COVID-19 booster shot most?
Sep 07, 2021
NCCN guidance says several groups should be considered eligible immediately for a third dose of either of the mRNA vaccines
FDA warns of heart-related events for arthritis drug Xeljanz and others in its class
Sep 02, 2021
The agency is requiring a warning label on the arthritis and ulcerative colitis drugs Xeljanz and Xeljanz XR (tofacitinib) and two other drugs in this class, citing an increased risk of adverse health...
Risk for psoriasis increased for cancer survivors
Jul 21, 2021
Increased risks seen for survivors of leukemia, lymphoma, multiple myeloma, skin cancer, and lung cancer in subgroup analyses